Post by Viralgen

𝗪𝗲 𝗵𝗮𝘃𝗲 𝘀𝗼𝗺𝗲 𝗻𝗲𝘄𝘀! We are partnering with #ElaajBio and LOULOU FOUNDATION to advance an investigational gene therapy for #CDKL5 Deficiency Disorder, a rare and severe neurological condition affecting children. We are supporting process development, scale-up manufacturing and analytical work to move this program toward its first clinical trial. #RareDisease programs like this one are exactly why we do what we do. ➜ Read the full press release: https://lnkd.in/enzhJ6W3 #AAV #CDMO #GeneTherapy #CDKL5DeficiencyDisorder #RarePediatric